Deborah M. Autor insider trades

Open-market stock purchases and sales by Deborah M. Autor, Chief Policy Officer at Hims & Hers Health, Inc, from SEC Form 4 filings since Dec 23, 2021.

Recent trades

DateStockTradeValue
Aug 18, 2026HIMS Hims & Hers Health, IncSold$467K
Aug 14, 2026HIMS Hims & Hers Health, IncSold (not open market)$455K
Aug 14, 2026HIMS Hims & Hers Health, IncBought (not open market)—
Aug 12, 2026HIMS Hims & Hers Health, IncBought (not open market)—
Jun 15, 2026HIMS Hims & Hers Health, IncSold (not open market)$464K
Jun 15, 2026HIMS Hims & Hers Health, IncBought (not open market)—
Jun 11, 2026HIMS Hims & Hers Health, IncBought (not open market)—
May 11, 2026AMRX Amneal Pharmaceuticals, IncSold$451K
May 7, 2026AMRX Amneal Pharmaceuticals, IncBought (not open market)—
May 6, 2026AMRX Amneal Pharmaceuticals, IncBought (not open market)—
Mar 13, 2026HIMS Hims & Hers Health, IncSold (not open market)$280K
Mar 13, 2026HIMS Hims & Hers Health, IncBought (not open market)—
Mar 11, 2026HIMS Hims & Hers Health, IncBought (not open market)—
Dec 17, 2025HIMS Hims & Hers Health, IncSold$259K
Dec 15, 2025HIMS Hims & Hers Health, IncBought (not open market)—

Companies traded

  • HIMS Hims & Hers Health, Inc: 2 sales, last Aug 18, 2026
  • AMRX Amneal Pharmaceuticals, Inc: 5 sales, last May 11, 2026
  • PRDS Pardes Biosciences, Inc: other filings, last Aug 31, 2023

Get free alerts when Deborah M. Autor files a new trade →